INSIGHTS ON DRUG DEVELOPMENT
-
Patented Process For Intermediates Useful For Deucravacitinib
Discover how this patented synthetic approach to Deucravacitinib intermediates can improve yield, simplify purification, and support scalable, regulatory-aligned manufacturing.
-
Silencing CDMO Project Noise: The Power Of Low-Drama Drug Development
Move beyond reactive firefighting by prioritizing disciplined leadership and data-driven milestones. The winning model for complex programs is focused, high-maturity, low-drama execution.
-
Introducing 2 New Highly Effective ADC Payloads For Cancer Therapeutics
Unlock the potential of antibody-drug conjugates (ADCs) by exploring our novel payloads, designed for easy access and evaluation, to accelerate your ADC drug development with proven efficacy and safety.
-
A Novel Patient-Derived Colorectal Cancer Organoid Platform
Patient-derived organoids are revolutionizing drug discovery by mimicking tumors and predicting therapeutic efficacy. Discover a scalable bioprocess that enhances reproducibility and cost-effectiveness to pave the way for broader adoption.
-
Development Of A High Sensitivity SPE-LC-MS/MS Assay7/29/2025
Achieve ultra-sensitive glucagon quantification with ionKey/MS, μElution SPE, and advanced MS fragmentation to deliver low LOD, reduced sample loss, and enhanced confidence in results.
-
A Faster, Human-Based Approach To AAV Optimization8/7/2024
Watch to learn about a human-relevant in vitro liver model and how it can be utilized to measure AAV transduction efficiency, evaluate the toxicity of AAV-based gene therapy vectors, and much more.
-
What Is DMPK, And Why Does It Matter In Drug Development?5/1/2025
By leveraging advanced DMPK software solutions, you can streamline your workflows and make informed decisions with confidence.
-
Integrating Phase-Appropriate Quality Standards12/9/2024
Incorporating phase-specific quality standards ensures GMP compliance. Collaborating with an experienced CDMO addresses late-stage quality needs and efficiently manages development timelines.
-
Increasing Precision And Cost Efficiency In The Lab With Gas Mixing3/9/2026
Understanding how cells function drives progress in disease research and drug discovery. Precise control of cellular environments is essential for reliable experiments and therapeutic development.
DRUG DEVELOPMENT SOLUTIONS
-
Optimize Your GC Analysis with Zebron GC Columns
Zebron GC columns are engineered with quality of analysis in mind to better support scientists' research and regulatory analysis for environmental, food safety, food quality, forensics, pharma, fuels, and specialty chemicals.
-
Our integrated approach brings together drug substance, drug product and clinical activities, supporting the expediting of lead molecules from FIH into POC trials.
-
As part of Stevanato Group’s commitment to R&D, our analytical testing facilities focus on investigating physico-chemical properties of primary packaging materials and components and studying the interactions between container closure system and drugs. Stevanato Group relies on a multi-disciplinary team of highly skilled professionals, including, scientists, engineers, pharmaceutical chemists and biotechnologists. Their knowledge and experience covers a range of specialized areas including container closure systems and drug-delivery devices.
-
Gain human-relevant insights with patient-derived assay-ready organoids.
-
Digital microscopy with automated brightfield, fluorescence, and Digital Confocal imaging
The ImageXpress® Pico Automated Cell Imaging System is more than a digital microscope, combining high-resolution imaging with powerful analysis. Whether running fluorescence imaging or brightfield assays, the automated imager features a comprehensive portfolio of preconfigured protocols for cell-based assays to shorten the learning curve, so you can start running experiments quickly.